Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Nuclear Medicine Diagnostic Market, by Region, 2019-2027 (USD Billion)
1.2.2. Nuclear Medicine Diagnostic Market, by Type, 2019-2027 (USD Billion)
1.2.3. Nuclear Medicine Diagnostic Market, by Modality, 2019-2027 (USD Billion)
1.2.4. Nuclear Medicine Diagnostic Market, by Application, 2019-2027 (USD Billion)
1.2.5. Nuclear Medicine Diagnostic Market, by Procedure, 2019-2027 (USD Billion)
1.2.6. Nuclear Medicine Diagnostic Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nuclear Medicine Diagnostic Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nuclear Medicine Diagnostic Market Dynamics
3.1. Nuclear Medicine Diagnostic Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising number of new cancer cases
3.1.1.2. Increasing adoption of SPECT and PET modality
3.1.2. Market Challenges
3.1.2.1. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Innovations in neurological applications
Chapter 4. Global Nuclear Medicine Diagnostic Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nuclear Medicine Diagnostic Market, by Type
5.1. Market Snapshot
5.2. Global Nuclear Medicine Diagnostic Market by Type, Performance - Potential Analysis
5.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
5.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
5.4.1. SPECT radiopharmaceuticals
5.4.2. PET radiopharmaceuticals
Chapter 6. Global Nuclear Medicine Diagnostic Market, by Modality
6.1. Market Snapshot
6.2. Global Nuclear Medicine Diagnostic Market by Modality, Performance - Potential Analysis
6.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Modality 2018-2027 (USD Billion)
6.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
6.4.1. SPECT
6.4.2. PET
6.4.3. Alpha-emitters
6.4.4. Beta-emitters
6.4.5. Brachytherapy
Chapter 7. Global Nuclear Medicine Diagnostic Market, by Application
7.1. Market Snapshot
7.2. Global Nuclear Medicine Diagnostic Market by Application, Performance - Potential Analysis
7.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
7.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
7.4.1. Cardiology
7.4.2. Thyroid
7.4.3. Neurology
7.4.4. Oncology
7.4.5. Others
Chapter 8. Global Nuclear Medicine Diagnostic Market, by Procedure:
8.1. Market Snapshot
8.2. Global Nuclear Medicine Diagnostic Market by Procedure, Performance - Potential Analysis
8.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by Procedure 2018-2027 (USD Billion)
8.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
8.4.1. Oncology
8.4.2. Cardiovascular
8.4.3. Central Nervous System
8.4.4. Endocrine
8.4.5. Skeletal
8.4.6. Gastrointestinal
8.4.7. Genito-urinary
8.4.8. Pulmonary
8.4.9. PET & PET-CT
8.4.10. Therapeutics
8.4.11. Others
Chapter 9. Global Nuclear Medicine Diagnostic Market, by End-User:
9.1. Market Snapshot
9.2. Global Nuclear Medicine Diagnostic Market by End-User, Performance - Potential Analysis
9.3. Global Nuclear Medicine Diagnostic Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
9.4. Nuclear Medicine Diagnostic Market, Sub Segment Analysis
9.4.1. Hospitals and diagnostic centres
9.4.2. Research Institutes
Chapter 10. Global Nuclear Medicine Diagnostic Market, Regional Analysis
10.1. Nuclear Medicine Diagnostic Market, Regional Market Snapshot
10.2. North America Nuclear Medicine Diagnostic Market
10.2.1. U.S. Nuclear Medicine Diagnostic Market
10.2.1.1. Type breakdown estimates & forecasts, 2018-2027
10.2.1.2. Modality breakdown estimates & forecasts, 2018-2027
10.2.1.3. Application breakdown estimates & forecasts, 2018-2027
10.2.2. Canada Nuclear Medicine Diagnostic Market
10.3. Europe Nuclear Medicine Diagnostic Market Snapshot
10.3.1. U.K. Nuclear Medicine Diagnostic Market
10.3.2. Germany Nuclear Medicine Diagnostic Market
10.3.3. France Nuclear Medicine Diagnostic Market
10.3.4. Spain Nuclear Medicine Diagnostic Market
10.3.5. Italy Nuclear Medicine Diagnostic Market
10.3.6. Rest of Europe Nuclear Medicine Diagnostic Market
10.4. Asia-Pacific Nuclear Medicine Diagnostic Market Snapshot
10.4.1. China Nuclear Medicine Diagnostic Market
10.4.2. India Nuclear Medicine Diagnostic Market
10.4.3. Japan Nuclear Medicine Diagnostic Market
10.4.4. Australia Nuclear Medicine Diagnostic Market
10.4.5. South Korea Nuclear Medicine Diagnostic Market
10.4.6. Rest of Asia Pacific Nuclear Medicine Diagnostic Market
10.5. Latin America Nuclear Medicine Diagnostic Market Snapshot
10.5.1. Brazil Nuclear Medicine Diagnostic Market
10.5.2. Mexico Nuclear Medicine Diagnostic Market
10.6. Rest of The World Nuclear Medicine Diagnostic Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. AMCS group
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Caverion corporation
11.2.3. Aerbin ApS
11.2.4. MariMatic Oy
11.2.5. Envac Group
11.2.6. Logiwaste AB
11.2.7. AWC Berhad Gropu
11.2.8. Ros Roca SA
11.2.9. Greenwave Solutions
11.2.10. STREAM environment
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption